Article Details

Neumora Completes $112M Series B to Develop Precision Neuro Therapies

Retrieved on: 2022-10-11 16:01:23

Tags for this article:

Click the tags to see associated articles and topics

Neumora Completes $112M Series B to Develop Precision Neuro Therapies. View article details on hiswai:

Excerpt

... and research collaboration with Vanderbilt University's Warren Center for Neuroscience Drug Discovery (WCNDD), announced in February.

Article found on: www.genengnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up